The molecular epidemiology of multidrug-resistant Acinetobacter baumannii was
investigated in the medical-surgical intensive care unit (ICU) of a university hospital in Italy …

BACKGROUND: Acinetobacter baumannii (Ab) is emerging as a multidrug-resistant (MDR)
nosocomial pathogen of considerable clinical importance. Data on the efficacy of infection …

Abstract Background Multidrug-resistant (MDR) Acinetobacter baumannii infections are
considered as emerging nosocomial infections particularly in patients hospitalized in …

To give an update on the molecular epidemiology and global distribution of carbapenemase
encoding genes, we subjected 313 carbapenem-resistant Acinetobacter baumannii isolated …

Acinetobacter baumannii is one of the most important antibiotic-resistant nosocomial
bacteria. We investigated changes in the clinical and molecular epidemiology of A …

Potential risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii were
investigated in a cohort study in 25 Spanish hospitals. The clonal relationship among …

BACKGROUND Acinetobacter baumannii (AB) has evolved a variety of resistance
mechanisms and exhibits unpredictable susceptibility patterns, making it difficult to select …

Antimicrobial resistance poses a serious threat to control infections due to ABC. Strategies to
curtail environmental colonization with MDR-ABD will require aggressive infection control …

Objective. To investigate the impact of antimicrobial resistance on clinical and economic
outcomes among hospitalized patients with multidrug-resistant (MDR) Acinetobacter …

Objectives We have investigated the molecular epidemiology and distribution of
carbapenemase genes in 492 imipenem-non-susceptible Acinetobacter baumannii …